SIDEBAR: Highlights From Fox Chase Cancer Center 

Get Permission

Fox Chase Cancer Center, Philadelphia, Pennsylvania

1945: Hugh J. Creech, PhD, begins his 31-year career at the Institute. Dr. Creech would become widely recognized for pioneering work in developing chemotherapy agents.

1959: Peter C. Nowell, MD, University of Pennsylvania School of Medicine, and his research fellow David A. Hungerford, Fox Chase Cancer Center [who subsequently earned his PhD], detect an abnormality on chromosome 22—the translocation now known as the Philadelphia chromosome—in cells taken from chronic myelogenous leukemia patients, proving cancer is a genetic disorder of somatic cells.

1960: Beatrice Mintz, PhD, joins the Institute. She would go on to produce the first genetically modified mice.

1967: Baruch S. Blumberg, MD, PhD, and his team identify the hepatitis B virus—a major cause of primary liver cancer. Blumberg would go on to receive the Nobel Prize in Medicine in 1976.

1974: Two years after the National Cancer Act begins the “War on Cancer,” American Oncologic Hospital and the Institute for Cancer Research unite to form Fox Chase Cancer Center.

Late 1970s: Irwin A. Rose, PhD, Avram Hershko, MD, PhD, and Aaron Ciechanover, MD, PhD, discover how proteins are broken down and recycled, establishing a new paradigm in biology. They received the Nobel Prize in chemistry in 2004.

1988: Robert C. Young, MD, internationally known for his work in ovarian cancer, becomes President of Fox Chase.

1992: The National Institutes of Health names Fox Chase one of four institutions chosen to analyze all genetic data for the Human Genome Project.

1995: Fox Chase becomes one of the founding members of the National Comprehensive Cancer Center Network, an alliance of the nation’s leading academic cancer centers dedicated to ensuring the highest-quality, most cost-effective cancer care based on state-of-the-art treatment guidelines and outcomes research.

2001: Fox Chase becomes the first cancer center in the world to use magnetic resonance imaging to design more precise radiation treatment plans for cancer patients, setting a new standard for therapy.

2013: Richard I. Fisher, MD, appointed President and CEO of Fox Chase Cancer Center

Adapted from Moments in Time: A History of Fox Chase Cancer Center. Available at Courtesy of Fox Chase Cancer Center. 

Related Articles

New President and CEO of Fox Chase Cancer Center Reflects on Challenges and Opportunities Ahead

On October 8, 1904, a group of Philadelphia physicians and businessmen who were concerned about the escalating incidence of cancer in the city signed a charter that established the American Oncologic Hospital, one of the nation’s first hospitals solely devoted to cancer care. Seven decades later—2...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.